Achieve Life Sciences (ACHV) Share-based Compensation (2010 - 2026)

Achieve Life Sciences' Share-based Compensation history runs 17 years deep, the most recent figure standing at $9.1 million for Q1 2026.

• Quarterly Share-based Compensation rose 307.71% year-over-year to $9.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.1 million (up 760.11% YoY) and the FY2025 annual result came in at $2.9 million, up 20.83% from the prior year.
• Share-based Compensation was $9.1 million for Q1 2026 at Achieve Life Sciences, up from -$7.5 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $9.1 million in Q1 2026 and bottomed at -$7.5 million in Q4 2025.
• A 5-year average of $1.2 million and a median of $1.3 million in 2024 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation soared 547.77% — and 2024, when it sank 216.71%.
• Achieve Life Sciences' Share-based Compensation stood at $3.2 million in 2022, then grew by 6.25% to $3.4 million in 2023, then sank by 216.71% to -$4.0 million in 2024, then tumbled by 88.0% to -$7.5 million in 2025, then soared by 221.98% to $9.1 million in 2026.
• Business Quant data shows ACHV's Share-based Compensation at $9.1 million in Q1 2026, -$7.5 million in Q4 2025, and $1.7 million in Q3 2025.